< Terug naar vorige pagina
Octrooi
Methylation status of gasdermin e gene as cancer biomarker
The present invention applies to the area of cancer diagnostics. In particular, the present invention is directed to a method for the ex vivo differential diagnosis between several cancer types in a subject based on the methylation status of the Gasdermin E (GSDME) gene. In a further aspect, the present invention relates to a method for the ex vivo differential diagnosis between several cancer types based on the methylation status of at least 2 CpG sites in the GSDME gene.
Octrooi-publicatienummer: WO2020178315
Jaar aanvraag: 2020
Jaar toekenning: 2021
Jaar van publicatie: 2020
Status: Aangevraagd
URI: link to Espacenet
Technologiedomeinen: Biotechnologie
Gevalideerd voor IOF-sleutel: Ja
Toegewezen aan: Associatie Universiteit & Hogescholen Antwerpen